DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients

Information source: Western Galilee Hospital-Nahariya
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Pain Relief

Intervention: Diclofenac hydroxyethylpyrrolidine (Drug); orphenadrine (Drug); Tramadol (Drug); Dipyrone (Drug)

Phase: N/A

Status: Not yet recruiting

Sponsored by: Western Galilee Hospital-Nahariya

Official(s) and/or principal investigator(s):
Nimrod Rahamimov, M.D., Principal Investigator, Affiliation: Western Galilee Hospital


The investigators will conduct a randomized double blind study, to determine whether patient analgesic delivery mode preference affects pain reduction quality in non-surgical spine patients. The patients will receive both intra-muscular and oral non-narcotic analgesics and placebo. During the study period, pain reduction parameters will be collected. At the end of the study period, the investigators will attempt to find a correlation between pre-study patient preferences and the quality of the pain reduction achieved.

Clinical Details

Official title: The Relationship Between Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Primary outcome: pain scores on visual analog scale

Secondary outcome:

Patient Questionnaire assessing pain and pain relief

patient preference Questionnaire


Minimum age: 15 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Patients with chronic and acute back pain

Exclusion Criteria:

- Recent Spine Surgery

Locations and Contacts

Western Galilee Hospital, Naharia, Israel; Not yet recruiting
Adi H Shani, R.N. , BA, Phone: +97249107200, Email: a_eilat@walla.com
Nimrod Rahamimov, M.D., Phone: +972507887564, Email: nimrod.rahamimov@naharia.health.gov.il
Nimrod Rahamimov, M.D., Principal Investigator
Additional Information

Starting date: December 2010
Last updated: December 16, 2010

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017